Gabriella Antignani — University of Helsinki

Phone+358504368911, +358294159680
Emailgabriella.antignanihelsinkifi

PL 56 (Viikinkaari 5)
00014
Finland

Research activity per year

Fields of Science

317 Pharmacy
Biological drugs

9 Article
2 Meeting Abstract
1 Review Article

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors
Feola, S., Hamdan, F., Russo, S., Chiaro, J., Fusciello, M., Feodoroff, M., Antignani, G., D'Alessio, F., Mölsä, R., Stigzelius, V., Bottega, P., Pesonen, S., Leusen, J., Grönholm, M. & Cerullo, V., 8 Mar 2024, In: Journal for ImmunoTherapy of Cancer. 12, 3, 16 p., e008342.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses
Hamdan, F., Feodoroff, M., Russo, S., Fusciello, M., Feola, S., Chiaro, J., Antignani, G., Greco, F., Leusen, J., Ylösmaki, E., Grönholm, M. & Cerullo, V., 16 Mar 2023, In: Molecular Therapy - Oncolytics. 28, p. 264-276 13 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors
Chiaro, J., Antignani, G., Feola, S., Feodoroff, M., Martins, B., Cojoc, H., Russo, S., Fusciello, M., Hamdan, F., Ferrari, V., Ciampi, D., Ilonen, I., Räsänen, J., Mäyränpää, M., Partanen, J., Koskela, S., Honkanen, J., Halonen, J., Kuryk, L., Rescigno, M., & 4 othersGrönholm, M., Branca, R. M., Lehtiö, J. & Cerullo, V., Dec 2023, In: Nature Communications. 14, 1, 16 p., 7056.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
Development of Oncolytic Adenovirus-Based Vaccine for Personalized Treatment of Malignant Mesothelioma
Chiaro, J., Antignani, G., Feola, S., Feodoroff, M., Martins, B., Cojoc, H., Ferrari, V., Ciampi, D., Ilonen, I., Rasanen, J., Mayranpaa, M., Partanen, J., Koskela, S., Kuryk, L., Russo, S., Fusciello, M., Hamdan, F., Rescigno, M., Gronholm, M., Branca, R., & 2 othersLehtio, J. & Cerullo, V., 1 May 2023, In: Molecular therapy. 31, 4, p. 667-668 2 p.
Research output: Contribution to journal › Article › Scientific › peer-review
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines
Feola, S., Chiaro, J., Martins, B., Russo, S., Fusciello, M., Ylösmäki, E., Bonini, C., Ruggiero, E., Hamdan, F., Feodoroff, M., Antignani, G., Viitala, T., Pesonen, S., Grönholm, M., Branca, R. M. M., Lehtiö, J. & Cerullo, V., 22 Mar 2022, In: eLife. 11, 21 p., 71156.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File

1 Active

Precision oncolytic immunotherapy for mesothelioma and renal cell carcinoma
Cerullo, V., Antignani, G., Chiaro, J. & Grönholm, M.
Suomen Akatemia Projektilaskutus
01/09/2023 → 31/08/2027
Project: Research Council of Finland: Academy Project